📈 The Top Analysis for Novo Nordisk A/S Sponsored ADR (NVO)

Novo Nordisk: A Weight Loss Revolution or a Stock in Distress?
Image

Fortune Magazine has described Novo Nordisk as spearheading a weight loss revolution, while others have hailed their leading product, OMIC, as a potential wonder drug reshaping healthcare.

🎯 What is the Current Sentiment for NVO?

The current sentiment is slightly bullish📈🚀
2 top investors currently rate NVO a buy

🔥 Which Investors Rated NVO a Buy?

💸 Novo Nordisk A/S Sponsored ADR (NVO) - What is the Conversation?

Check out the top conversations on NVO
Image

General 08/05/2025

Image

General 06/23/2025

Image

General 06/24/2025

NVO
Novo Nordisk A/S Sponsored ADR
Market Cap
$246,973,743,104.00
52 Week High
$139.74
PE Ratio
0.439
52 Week Low
$45.05
EPS
$3.89
Shares Outstanding
693,095,252.00
Dividend Yield
2.83%
Dividend Per Share
$1.61
PoweredByInsightfulIR
Resources for Publishers
Resources for New Investors
Stock Selection Guides (SSG) - A New Investor Guide
BetterInvesting™ Resources
Partner Resources
The Top Stock Selection Guide Picks
Understanding the Stock Selection Guide


Utility Stocks - A New Investor Guide
Best Utility Stocks to Invest in


Value Investing - Strategy Basics
Resources
Is Value Investing Right for you?
Implementing a Value Strategy


A Guide to Metaverse Stocks
How to Invest
How the Metaverse Makes Money
Metaverse Investment Analysis


A Guide to Industrial Stocks


A Guide to Finance Stocks


A Guide to Healthcare Stocks
How to Invest
Which is a Better Buy in Healthcare?
Critical Healthcare Stocks Analyzed


A Guide to Material Stocks


A Guide to Telecom Stocks